Ra Medical Systems (NYSE:RMED) and IceCure Medical (NASDAQ:ICCM) Head to Head Analysis

Medical IceCure (NASDAQ:ICCMget rating) and Ra Medical Systems (New York Stock Exchange:RMEDget rating) are both medical companies, but which is the better deal? We will compare the two businesses based on the strength of their analyst recommendations, earnings, risk, valuation, profitability, institutional ownership, and dividends.

Cost effectiveness

This table compares the net margins, return on equity, and return on assets of IceCure Medical and Ra Medical Systems.

net margins Return on equity Return on assets
IceCure Medical N/A N/A N/A
Ra medical systems -1,175.34% -168.49% -117.70%

Internal and institutional ownership

6.9% of Ra Medical Systems shares are owned by institutional investors. 12.3% of Ra Medical Systems shares are owned by insiders of the company. Strong institutional ownership is an indication that large fund managers, endowments and hedge funds believe a stock is poised for long-term growth.

Analyst Recommendations

This is a summary of current ratings for IceCure Medical and Ra Medical Systems, provided by MarketBeat.com.

sales ratings retention ratings Buy grades Strong purchase ratings Rating Score
IceCure Medical 3 3.00
Ra medical systems one 3.00

IceCure Medical currently has a consensus price target of $7.58, indicating a potential increase of 210.45%. Ra Medical Systems has a consensus price target of $12.00, indicating 3,619.78% upside potential. Given the highest possible advantage of Ra Medical Systems, analysts clearly believe that Ra Medical Systems is more favorable than IceCure Medical.

Earnings and Valuation

This table compares the gross revenue, earnings per share, and valuation of IceCure Medical and Ra Medical Systems.

Gross income Price/Sales Ratio Net income earnings per share Rate of earnings on price
IceCure Medical $4.14 million N/A -9.90 million dollars N/A N/A
Ra medical systems $20,000.00 507.43 -$25.07 million ($5.66) -0.06

IceCure Medical has higher revenue and profit than Ra Medical Systems.


IceCure Medical outperforms Ra Medical Systems in 6 of 9 factors compared between the two stocks.

About IceCure Medical (get rating)

IceCure Medical Ltd researches, develops and markets minimally invasive cryoablation systems for the oncology and women’s health markets. Offers the ProSense system, a cryoablation solution for breast tumors. The company was founded in 2006 and is headquartered in Caesarea, Israel.

About Ra Medical Systems (get rating)

Ra Medical Systems, Inc., a medical device company, develops, manufactures and markets excimer lasers for use in the treatment of vascular and dermatological diseases. It offers destruction of atherosclerotic blockages by laser radiation ablation, a minimally invasive excimer laser and single-use catheter system used by physicians in the endovascular treatment of vascular blockages resulting from vascular disease in the lower extremities. The company sells its products primarily through distributors in the United States. Ra Medical Systems, Inc. was incorporated in 2002 and is headquartered in Carlsbad, California.

Receive news and ratings for IceCure Medical Daily – Enter your email address below to receive a concise daily summary of the latest news and analyst ratings for IceCure Medical and related companies with MarketBeat.com’s FREE daily email newsletter.

See also  Why it seems like the world has abandoned Brittney Griner